Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis. - Wikidata - thesis-toulmin - TriplyDB

Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.

Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34132273

about

Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures.Prothrombin complex concentrates in warfarin anticoagulation reversal.Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin.Emergency management of major bleeding in a case of maxillofacial trauma and anticoagulation: utility of prothrombin complex concentrates in the shock room.Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.Statins as a preventative therapy for venous thromboembolism.The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism.Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia.

P2860

Q33431119-D247B734-06CD-4248-A96C-93DAA5BFDAA2 Q33832680-00E04BE8-2F58-48D5-AFB3-0681EAB201FC Q34276182-C2433D85-BCED-4940-B858-A686D0BF0FBD Q36341724-FFE924A6-C866-4FFF-8AFA-C2B5259DD74F Q38049617-C5E44DF2-7252-401D-9BB7-D8CD00997F4B Q38068113-82A090FF-D07A-481A-BA3F-277A2E98B035 Q42016264-C35DEE27-AF78-476D-9E72-6D84AAF8083F Q42354433-D33788E4-C4D2-40F0-8712-81E8A52C7230 Q42674490-6481BE6B-ACB9-4DBF-A5DD-513F0C8775A0 Q42676674-2A5EF132-68C4-42F6-A1B7-ED6578B2AF80 Q49265793-0E145F77-401B-4100-989F-5F7EB93FEF83 Q51515902-1EC269B4-D1A8-49AE-A5B6-3B70D0651C33 Q53099910-3999899C-DEFE-420D-B8C4-21592AB9C40C

P2860

Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34132273

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Bleeding risk in randomized co ...... atic review and meta-analysis.

@ast

Bleeding risk in randomized co ...... atic review and meta-analysis.

@en

Bleeding risk in randomized co ...... atic review and meta-analysis.

@nl

type

label

Bleeding risk in randomized co ...... atic review and meta-analysis.

@ast

Bleeding risk in randomized co ...... atic review and meta-analysis.

@en

Bleeding risk in randomized co ...... atic review and meta-analysis.

@nl

prefLabel

Bleeding risk in randomized co ...... atic review and meta-analysis.

@ast

Bleeding risk in randomized co ...... atic review and meta-analysis.

@en

Bleeding risk in randomized co ...... atic review and meta-analysis.

@nl

P1433

Q34132273-7DB1AFC6-0589-4F1A-8393-0F64E6A87501

P1476

Q34132273-9F56C761-A0FA-407C-A47C-A220D1D67A5A

P2093

Q34132273-AA57EBFB-0153-437B-9520-77DBDAE327B3

Q34132273-BBF56BC3-E06A-4214-AE37-3EDC44D2F46B

Q34132273-E32B6825-2B6F-44AA-A7A7-302C95074553

Q34132273-EB488E9A-5CD1-43B7-AB9D-A8C02B2164A6

Q34132273-EBA7BE72-407B-403D-9F76-A64CF5AFB408

P2860

Q34132273-2D5D9DE8-3C87-4795-B227-B66731FD95D6

Q34132273-3C4075CB-8282-44E3-87CA-99888B59C8F4

Q34132273-4AAD346A-C69A-4BD0-A66C-105AFAC6D2B0

Q34132273-66954075-108F-48EB-BBB4-587009359DBD

Q34132273-88E6B5DB-2D95-4348-A1FC-2E7586526694

Q34132273-890663A3-F1E5-40D9-9F15-A51A1A738863

Q34132273-8A04583D-BEBB-4E43-8A68-4E68B218A563

Q34132273-9359620C-DF98-4924-985E-C50FE54AFE38

Q34132273-96C623ED-F4EC-485F-815C-F17387E97C8B

Q34132273-98276751-CCEB-460B-B629-408418643622

P304

Q34132273-5BBB14A4-31BA-45EE-A7DA-D0F9A74E9880

P31

Q34132273-0A5066EE-3E31-4755-87DD-E9A3FA8FDE5C

Q34132273-5b23e13e-f3c4-4872-97f7-200347cd7f6f

P356

Q34132273-9F177723-2EB3-4E86-995D-1396BD2DBD05

P433

Q34132273-D2AF9EA9-E72D-4E0B-A8C8-C8690DC3CEDF

P478

Q34132273-C168A284-DCDC-49F1-A821-B2B6079D12BC

P577

Q34132273-763B80C2-B2B0-4BA5-8824-F2B200B3E12B

P5875

Q34132273-62EEFCC9-F43C-4C11-9B90-61BADFABEC0B

P698

Q34132273-8AD446D1-3F3E-4622-9F13-9940B6E3B822

P921

Q34132273-20A8B215-7873-47C2-ABA5-CD3A6FBB3A56

P356

J.1538-7836.2012.04635.X

P1433

Journal of Thrombosis and Haemostasis

P1476

Bleeding risk in randomized co ...... atic review and meta-analysis.

@en

P2093

A E Warkentin

http://www.w3.org/2001/XMLSchema#string

F A Spencer

http://www.w3.org/2001/XMLSchema#string

M Crowther

http://www.w3.org/2001/XMLSchema#string

M P Donadini

http://www.w3.org/2001/XMLSchema#string

W Lim

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)

Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials

Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease

Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

P304

512-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2012.04635.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221758877

http://www.w3.org/2001/XMLSchema#string

P698

22257078

http://www.w3.org/2001/XMLSchema#string

P921